# Scopus BioPharma Inc. — Form D

Scopus BioPharma Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2021-12-07. The offering totals $9.8M, of which $9.8M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2021-12-07
- Form: D
- Accession: 0001104659-21-147286
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $9.8M
- Amount sold: $9.8M
- Investors: 4
- Date of first sale: 2021-11-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-424033

## Issuer

- Name: Scopus BioPharma Inc.
- CIK: 0001772028
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 420 LEXINGTON AVE., NEW YORK, NY, 10170
- Phone: 212-479-2513

## Officers, directors & promoters (21)

| Name | Role | Location |
| --- | --- | --- |
| David S Battleman | Director | New York, NY |
| David A Buckel | Director | New York, NY |
| Robert J Gibson | Director | New York, NY |
| Ira Scott Greenspan | Director | New York, NY |
| Raphael A Hofstein | Director | New York, NY |
| Paul E Hopper | Director | New York, NY |
| Joshua Lamstein | Director | Wayland, MA |
| Ashish P Sanghrajka | Director | New York, NY |
| David P Weild | Director | New York, NY |
| Robert J Gibson | Executive Officer | New York, NY |
| Ira Scott Greenspan | Executive Officer | New York, NY |
| Joshua Lamstein | Executive Officer | Wayland, MA |
| Ashish P Sanghrajka | Executive Officer | New York, NY |
| Joshua R Lamstein | Director | New York, NY |
| Joshua R Lamstein | Executive Officer | New York, NY |
| Paul R Hopper | Director | New York, NY |
| Paul R Hopper | Executive Officer | New York, NY |
| Paul J Hopper | Director | New York, NY |
| Paul J Hopper | Executive Officer | New York, NY |
| Morris C Laster | Director | New York, NY |
| Morris C Laster | Executive Officer | New York, NY |

## Other filings by this issuer (5)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2020-07-10](https://search.stillhousedata.com/formd/0001772028-20-000001) | D | $500K | $252K |
| [2020-07-10](https://search.stillhousedata.com/formd/0001772028-20-000003) | D | $636K | $636K |
| [2020-07-10](https://search.stillhousedata.com/formd/0001772028-20-000004) | D | $6.3M | $6.3M |
| [2020-07-10](https://search.stillhousedata.com/formd/0001772028-20-000002) | D/A | $2.3M | $1.9M |
| [2019-08-08](https://search.stillhousedata.com/formd/0001772028-19-000002) | D | $600K | $451K |

## More

- [CIK 1772028 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1772028&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001104659-21-147286.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.